About HERTI
"HERTI" belongs to Anti Neoplastics therapy of Oncology Division and it is available in 2 forms : Herti 150 Mg Injection and Herti 440 Mg Injection.
(Read More)
Herti is a HER2-targeted monoclonal antibody indicated for the treatment of HER2-positive breast and gastric cancers. It binds to the HER2 receptor, inhibiting downstream signaling pathways that drive cancer cell growth and survival.
